Thermal and fractal analysis of diclofenac/gelucire 50/13 microparticles obtained by ultrasound-assisted atomization

Journal of Pharmaceutical Sciences

Volumn 94, Issue 5, 2005, Pages 1124-1134

  Cavallari, Cristina ^a   Rodriguez, Lorenzo ^a   Albertini, Beatrice ^a   Passerini, Nadia ^a   Rosetti, Francesca ^a   Fini, Adamo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Diclofenac; DSC, HSM, and XRD analysis; Enhanced dissolution; Fractal dimension; Microparticles; Ultrasound assisted spray congealing

Indexed keywords

DICLOFENAC; EXCIPIENT; GELUCIRE;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; FRACTAL ANALYSIS; HOT STAGE MICROSCOPY; IMAGE ANALYSIS; MICROENCAPSULATION; MICROSCOPY; NEBULIZATION; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SOLID STATE; THERMAL ANALYSIS; ULTRASOUND; X RAY POWDER DIFFRACTION;

EID: 20344387251     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20337     Document Type: Article

References (32)

1. Wadke DA, Serajuddin ATM, Jacobson H. 1989. Preformulation testing. In: Lieberman HA, Lachman L, Schwartz JB, editors. Pharmaceutical dosage forms: Tablets. New York: Dekker, pp 1-73.
2. Serajuddin ATM. 1999. Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems and recent breakthroughs. J Pharm Sci 88:1058-1066.
3. Leuner C, Dressman J. 2000. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 50:47-60.
4. Chiou WL, Riegelman S. 1971. Pharmaceutical applications of solid dispersion systems. J Pharm Sci 60:1281-1302.
5. Ford JL. 1986. The current status of solid dispersions. Pharm Acta Helv 61:69-88.
6. Witschi C, Doelker E. 1997. Residual solvents in pharmaceutical products: Acceptable limits, influence on physicochemical properties, analytical methods, and documented values. Eur J Pharm Biopharm 43:215-242.
7. Killeen MJ. 1996. Spray drying and spray congealing of pharmaceutics. In: Swarbrick J, Boylan J, editors. Encyclopedia of pharmaceutical technology. New York, NY: Marcel Dekker, pp 207-221.
8. Giunchedi P, Conte U. 1995. Spray drying as a preparation method of microparticulate drug delivery system. An overview. STP Pharm Sci 5:276-290.
9. Rodriguez L, Passerini N, Cavallari C, Cini M, Sancin P, Fini A. 1999. Description and preliminary evaluation of a new ultrasonic atomizer for spray-congealing processes Int J Pharm 183:133-143.
10. Fini A, Moyano JR, Ginés JM, Perez-Martinez JI, Rabasco AM. 2004. Diclofenac salts, II. Solid dispersions in PEG-6000 and Gelucire 50/13. Eur J Pharm Biopharm (in press).
11. Serajuddin ATM, Sheen RC, Mufson D, Bernstein DF, Augustine MA. 1988. Physicochemical basis of increased bioavailability of a poorly water-soluble drug following oral administration as organic solutions. J Pharm Sci 77:325-329.
12. Serajuddin ATM, Sheen PC, Augustine MA. 1990. Improved dissolution of a poorly water-soluble drug from solid dispersions in polyethylene glycol:polysorbate 80 mixtures. J Pharm Sci 79:463-464.
13. Sheen PC, Khetarpl VK, Cariola CM, Rowlings CE. 1995. Formulation studies of a poorly water soluble drug in solid dispersion to improve bioavailability. Int J Pharm 118:221-227.
14. Fini A, Garuti M, Fazio G, Alvarez-Fuentes J, Holgado MA. 2001. Diclofenac salts. I. Fractal and thermal analysis of sodium and potassium diclofenac salts. J Pharm Sci 90:2049-2057.
15. O'Connor KM, Corrigan OI. 2001. Comparison of the physicochemical properties of the N-(2-hydroxyethyl) pyrrolidine, diethylamine and sodium salt forms of diclofenac. Int J Pharm 222:281-293.
16. Ledwidge MT, Draper SM, Wilcock DJ, Corrigan OI. 1996. Physicochemical characterization of diclofenac N-(2-hydroxyethyl)pyrrolidine: Anhydrate and dihydrate crystalline forms. J Pharm Sci 85:16-21.
17. Gelucire 50/13. 1999. Controlled and enhanced bioavailability, 1st edn. Paris: Gattefossé Technical Literature.
18. Craig DQM. 1996. The physical characterisation of Gelucire 50/13. In: Gattefossé SA, editor. Bulletin technique Gattefossé, No. 89. Cedex, France: Saint Priest, pp 39-50.
19. Craig DQM. 1995. The use of glycerides as controlled release matrices. In: Karsa DR, Stephenson RA, editors. Excipients and delivery systems for pharmaceutical formulations. Cambridge: Royal Society of Chemistry, pp 148-174.
20. Passerini N, Perissutti B, Moneghini M, Voinovich D, Albertini B, Cavallari C, Rodriguez L. 2002. Characterization of carbamazepine-Gelucire 50/13 microparticles prepared by a spray-congealing process using ultrasounds. J Pharm Sci 91:699-707.
21. Ginés JM, Veiga MD, Arias MJ, Rabasco AM. 1995. Elaboration and thermal study of interactions between cinnarizine and Gelucire 53/10 mixtures and solid dispersions. Int J Pharm 126:287-291.
22. Gohel MC, Amin AF. 1999. Formulation design and optimization of modified release microsphere diclofenac sodium. Drug Dev Ind Pharm 25:247-254.
23. Concessio NM, Hickey AJ. 1997. Descriptors of irregular particle morphology and powder properties. Adv Drug Deliv Rev 26:29-40.
24. Farin D, Avnir D. 1992. Use of the fractal geometry to determine effects on drug dissolution. J Pharm Sci 81:54-57.
25. Serajiuddin ATM, Sheen PC, Mufson D, Bernstein DF, Augustin MA, 1988. Effect of the vehicle amphiphilicity on the dissolution and bioavailability of a poor water solubility from solid dispersion. J Pharm Sci 77:414-417.
26. Fini A, Fernandez-Hervas MJ, Holgado MA, Cavallari C, Passerini N. 1996. Application of fractal geometry and image analysis to evaluate a new spray-congealing technique. Acta Techol Leg Med 2:113-128.
27. Sutananta W, Craig DQM, Newton JM. 1994. The effects of ageing on the thermal behaviour and mechanical properties of pharmaceutical glycerides. Int J Pharm 111:51-62.
28. Sutananta W, Craig DQ, Newton JM. 1995. An investigation into the effects of preparation conditions and storage on the rate of drug release from pharmaceutical glyceride bases. J Pharm Pharmacol 47:355-359.
29. Damian F, Blaton N, Naesens L, Balzarini J, Kinget R, Augustijns P, Van Der Mooter G. 2000. Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur J Pharm Sci 10:311-322.
30. Khan N, Craig DQM. 2003. The influence of drug incorporation on the structure and release properties of solid dispersions in lipid matrices. J Control Release 93:355-368.
31. Perissutti B, Rubessa F, Princivalle F. 2000. Solid dispersions of carbamazepine with Gelucire 44/14 and 50/13. STP Pharm Sci 10:479-484.
32. Fini A., Fazio G., Rabasco AM, Fernandez-Hervas MJ. 1994. Self-association properties of diclofenac. Il Farmaco 49:141-146.